中国医药科学Issue(12)：62-64,3.
康艾注射液联合化疗治疗晚期肺癌55例疗效观察
Clinical efficacy of Kang'ai injection combined with chemotherapy in treatment of advanced lung cancer:An observation of 55 cases
张盛奇 1林丽芳 1郑泓斌 1邱希辉 1庄晓文 1陈志明1
作者信息
- 1. 汕头大学医学院附属肿瘤医院中西医结合科，广东汕头515031
- 折叠
摘要
Abstract
Objective To discuss improvement of term clinical efficacy, quality of life and relief of adverse reactions caused by chemotherapy of Kang'ai injection combined with chemotherapy in treatment of advanced lung cancer. Methods Selected 55 cases with advanced lung cancer were randomly divided into treatment group with 30 cases and control group with 25 cases. Treatment group were treated with Kang'ai injection combined with chemotherapy, and control group received Chemotherapy. Results term clinical efficacy of two groups were 60% and 56%, without significant different between two groups(P > 0.05); kps score after treatment,improvement rates of quality of life of treatment and control group were 90%and 72%, with significant different between two groups;Gastrointestinal response rate from 0 to 1 degree, treatment group was 90%, which was higher than 72%of control group;Gastrointestinal response rate from 2 to 4 degree of treatment group was lower than 28%of control group (P<0.05). 2 to 4 degree of bone marrow suppression rate of treatment group was 30%,which was lower than 44%of control group (P<0.05). Adverse reaction rate of control group was higher than treatment group (P<0.05). Conclusion Kang'ai injection combined with chemotherapy in treatment of non-small cell lung cancer shows fairly efficacy of chemotherapy with chemotherapy Kang'ai injection, and can improve quality of life, relief adverse reactions, worthy of cilinical promotion.关键词
康艾注射液/化疗/晚期肺癌Key words
Kang'ai injection/Chemotherapy/Advanced lung cancer分类
医药卫生引用本文复制引用
张盛奇,林丽芳,郑泓斌,邱希辉,庄晓文,陈志明..康艾注射液联合化疗治疗晚期肺癌55例疗效观察[J].中国医药科学,2014,(12):62-64,3.
